tirzepatide going off market Trends, Share and Forecast, 2026-2033 Compounders protest as FDA removes

Access, Cost, and Equity These drugs are often expensive, rarely covered by insurance for weight management alone, and disproportionately marketed to affluent, thin-adjacent people

(Source: Segmental Insights Product Type Insights Why Did Injectable GLP-1 Analogues Dominate the Market in 2025

strong pain medication, and over-the-counter herbs and supplements, like St

There is generally no charge to join a clinical trial, although study-related costs and reimbursements vary by protocol and site

Many individuals describe this as the medication's 'switch' turning on, where overeating simply feels uncomfortable

Too much insulin can be dangerous and lead to seizures or even death